BRAF and thyroid gland carcinoma: We next evaluated the accumulation of total FAK in thyroid cancer cell lines expressing BRAF V600E mutations due to their association with recurrence, extrathyroidal extension, advanced stage, and distant metastases in thyroid cancer (26, 39).